Drug intelligence / Profile preview

Gujin Granule + Shengmai Injection + cisplatin + vinorelbine

Development stage
Preclinical
Lead developer
Beijing Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a combination therapy consisting of two traditional Chinese medicine (TCM) products—Gujin Granule and Shengmai Injection—together with two chemotherapeutic agents, cisplatin and vinorelbine. Gujin Granule is a complex herbal formulation based on Baihe Gujin Tang, traditionally used in TCM for nourishing yin and treating chronic lung diseases; its composition includes multiple herbs such as Scrophulariae, Platycodon, Paeoniae, and Glycyrrhizae[2]. Shengmai Injection is derived from the classic formula Shengmai San (containing ginseng, ophiopogon root, and schisandra fruit), commonly used to tonify qi and fluids in TCM. Cisplatin is a platinum-based chemotherapy that forms DNA crosslinks to inhibit cancer cell replication. Vinorelbine is a third-generation vinca alkaloid that inhibits microtubule assembly during mitosis[6][8][10]. This combination has been explored primarily for the treatment of non-small cell lung cancer (NSCLC), aiming to integrate the cytotoxic effects of chemotherapy with potential supportive or synergistic effects from TCM components.

02

Targets

TUBB (Tubulin (alpha and beta subunits))DNA

Beyond the preview

Go deeper on Gujin Granule + Shengmai Injection + cisplatin + vinorelbine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gujin Granule + Shengmai Injection + cisplatin + vinorelbine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call